C-MER Eye Care Holdings Limited (3309.HK)
HKD 1.39
(0.72%)
HKD 1.39
(0.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 380.74 Million | 191.85 Million | 148.41 Million | 104.03 Million | 140.55 Million | 40.9 Million |
| Net Income | 61.99 Million | -21.87 Million | 21.86 Million | -6.24 Million | 41.43 Million | 42.57 Million |
| Depreciation & Amortization | 220.65 Million | 223.68 Million | 148.58 Million | 113.56 Million | 78.53 Million | 25.54 Million |
| Deferred income taxes | - | -483.16 Million | -309.42 Million | -236.59 Million | -164.78 Million | -5.36 Million |
| Stock-based compensation | 273 Thousand | 1.33 Million | 4.25 Million | 5.01 Million | 4.87 Million | 6.54 Million |
| Change in working capital | 50.97 Million | -32.72 Million | -7.41 Million | -1.47 Million | 14.52 Million | -1.18 Million |
| Other non-cash items | 472.51 Million | 504.61 Million | 290.55 Million | 229.76 Million | 165.96 Million | -27.21 Million |
| Investing Cash Flow | -264.62 Million | -210.65 Million | -392.72 Million | -157.94 Million | -264.02 Million | -274.6 Million |
| Investments in PPE | -115.85 Million | -91.22 Million | -129.22 Million | -337.41 Million | -171.91 Million | -31.69 Million |
| Acquisitions | -137.73 Million | -80.26 Million | -223.48 Million | -39.31 Million | -96.31 Million | 202 Thousand |
| Investment purchases | -11.03 Million | -39.16 Million | -40 Million | -34.91 Million | -6.97 Million | -16.5 Million |
| Sales/Maturities of investments | - | 106.68 Million | 277.58 Million | 253.71 Million | 11.16 Million | 4.79 Million |
| Other Investing Activities | -129.88 Million | -106.68 Million | -277.58 Million | -116.61 Million | 1.00 | -231.39 Million |
| Financing Cash Flow | -243.21 Million | 281.64 Million | 78.1 Million | 322.36 Million | -65.75 Million | 630.43 Million |
| Debt repayment | -32.49 Million | -161.98 Million | -174.45 Million | -55.47 Million | -46.35 Million | -8.7 Million |
| Dividends payments | - | - | -22.96 Million | -21.51 Million | -21.02 Million | - |
| Common Stock Repurchased | -58.29 Million | -29.92 Million | -88.63 Million | -333.53 Million | 45.58 Million | - |
| Common Stock Issuance | - | 607.66 Million | 9.24 Million | 399.36 Million | 1.61 Million | 657.55 Million |
| Other Financing Activities | -4.4 Million | -1.2 Million | 354.9 Million | 333.53 Million | -45.57 Million | -18.41 Million |
| Accounts receivables | -6.52 Million | -26.69 Million | -18.54 Million | -3.12 Million | -4.39 Million | 1.32 Million |
| Accounts payables | 10.56 Million | 887 Thousand | 19.74 Million | 4.25 Million | 5.22 Million | -1.36 Million |
| Inventory | 11.86 Million | -8.65 Million | -9.21 Million | -5.58 Million | -3.66 Million | -2.5 Million |
| Other working capital | 35.07 Million | 1.74 Million | 590 Thousand | 2.97 Million | 17.36 Million | 1.36 Million |
| Cash at beginning of period | 644.69 Million | 386.65 Million | 553.93 Million | 282.17 Million | 471.74 Million | 77.96 Million |
| Cash at end of period | 512.76 Million | 644.69 Million | 386.65 Million | 553.93 Million | 282.17 Million | 471.74 Million |
| Capital Expenditure | -115.85 Million | -91.22 Million | -129.22 Million | -337.41 Million | -171.91 Million | -31.69 Million |
| Effect of forex changes on cash | -4.84 Million | -4.8 Million | -1.06 Million | 3.29 Million | -335 Thousand | -2.96 Million |
| Net cash flow / Change in cash | -131.93 Million | 258.03 Million | -167.27 Million | 271.75 Million | -189.56 Million | 393.77 Million |
| Free Cash Flow | 264.88 Million | 100.63 Million | 19.18 Million | -233.38 Million | -31.35 Million | 9.2 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 61.99 Million | 32.24 Million | 29.75 Million | -21.87 Million | -36.69 Million | 14.81 Million |
| Depreciation & Amortization | 220.65 Million | 107.82 Million | 113.16 Million | 223.68 Million | 113.56 Million | 110.34 Million |
| Deferred income taxes | - | - | - | -483.16 Million | -191.6 Million | - |
| Stock-based compensation | 273 Thousand | 185 Thousand | 88 Thousand | 1.33 Million | 287 Thousand | 1.04 Million |
| Change in working capital | 50.97 Million | 24.74 Million | - | -32.72 Million | -63.79 Million | - |
| Other non-cash items | 472.51 Million | 769 Thousand | 52.38 Million | 504.61 Million | 51.79 Million | 216.83 Million |
| Investing Cash Flow | -264.62 Million | -77.17 Million | -168.19 Million | -210.65 Million | -105.94 Million | -111.75 Million |
| Investments in PPE | -115.85 Million | -70.83 Million | -44.64 Million | -91.22 Million | -52.19 Million | -37.69 Million |
| Acquisitions | -137.73 Million | 152.89 Million | -152.89 Million | -80.26 Million | -20.26 Million | -74.06 Million |
| Investment purchases | -11.03 Million | -11.03 Million | 123.55 Million | -39.16 Million | -39.16 Million | - |
| Sales/Maturities of investments | - | -19.87 Million | 19.87 Million | 106.68 Million | 53.74 Million | - |
| Other Investing Activities | -129.88 Million | -159.23 Million | 29.34 Million | -106.68 Million | -33.48 Million | 21.11 Million |
| Financing Cash Flow | -243.21 Million | -140.6 Million | -102.26 Million | 281.64 Million | 53.32 Million | 240.75 Million |
| Debt repayment | -32.49 Million | -11.06 Million | -86.34 Million | -161.98 Million | -180.47 Million | -180.47 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -58.29 Million | -54.31 Million | -3.98 Million | -29.92 Million | -29.92 Million | - |
| Common Stock Issuance | - | - | - | 607.66 Million | 115.85 Million | 491.81 Million |
| Other Financing Activities | -4.4 Million | -86.29 Million | -11.94 Million | -1.2 Million | 83.24 Million | -5.33 Million |
| Accounts receivables | -6.52 Million | -6.52 Million | - | -26.69 Million | -26.69 Million | - |
| Accounts payables | 10.56 Million | - | - | 887 Thousand | - | - |
| Inventory | 11.86 Million | 11.86 Million | - | -8.65 Million | -8.65 Million | - |
| Other working capital | 35.07 Million | 19.39 Million | - | 1.74 Million | -28.43 Million | - |
| Cash at beginning of period | 644.69 Million | 563.11 Million | 644.69 Million | 386.65 Million | 631.69 Million | 386.65 Million |
| Cash at end of period | 512.76 Million | 512.76 Million | 563.11 Million | 644.69 Million | 644.69 Million | 631.69 Million |
| Capital Expenditure | -115.85 Million | -70.83 Million | -44.64 Million | -91.22 Million | -52.19 Million | -37.69 Million |
| Effect of forex changes on cash | -4.84 Million | 1.66 Million | -6.5 Million | -4.8 Million | 454 Thousand | -5.26 Million |
| Net cash flow / Change in cash | -131.93 Million | -50.35 Million | -81.57 Million | 258.03 Million | 12.99 Million | 245.04 Million |
| Free Cash Flow | 264.88 Million | 94.92 Million | 150.74 Million | 100.63 Million | 12.96 Million | 83.61 Million |
ACRDF
1816
IMTX
SGLD
WKRCF
RADIXIND